Drugs
April 2008: Additions and Deletions to the Drug Product List
28th Edition: Cumulative Supplement Number 4
Prescription OTC
CS Preface Cumulative Supplement Legend.
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST
ACARBOSE
TABLET; ORAL
>A> ACARBOSE
>A> AB COBALT LABS INC 25MG N77532 001 May 07, 2008 Apr NEWA
>A> AB 50MG N77532 002 May 07, 2008 Apr NEWA
>A> AB 100MG N77532 003 May 07, 2008 Apr NEWA
>A> AB ROXANE 25MG N78470 001 May 07, 2008 Apr NEWA
>A> AB 50MG N78470 002 May 07, 2008 Apr NEWA
>A> AB 100MG N78470 003 May 07, 2008 Apr NEWA
PRECOSE
>D> BAYER PHARMS 25MG N20482 004 May 29, 1997 Apr CFTG
>A> AB 25MG N20482 004 May 29, 1997 Apr CFTG
>D> 50MG N20482 001 Sep 06, 1995 Apr CFTG
>A> AB 50MG N20482 001 Sep 06, 1995 Apr CFTG
>D> 100MG N20482 002 Sep 06, 1995 Apr CFTG
>A> AB 100MG N20482 002 Sep 06, 1995 Apr CFTG
ACETAMINOPHEN; HYDROCODONE BITARTRATE
SOLUTION; ORAL
HYDROCODONE BITARTRATE AND ACETAMINOPHEN
>A> + PHARM ASSOC 325MG/15ML;10MG/15ML N40834 001 Apr 18, 2008 Apr NEWA
ALBUTEROL SULFATE; IPRATROPIUM BROMIDE
SOLUTION; INHALATION
ALBUTEROL SULFATE AND IPRATROPIUM BROMIDE
>D> AN BREATH LTD EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Apr CAHN
>A> AN COBALT LABS INC EQ 0.083% BASE;0.017% N77063 001 Dec 31, 2007 Apr CAHN
AMIODARONE HYDROCHLORIDE
INJECTABLE; INJECTION
AMIODARONE HYDROCHLORIDE
>D> AP + BEN VENUE 50MG/ML N76088 001 Oct 15, 2002 Apr DISC
>A> @ 50MG/ML N76088 001 Oct 15, 2002 Apr DISC
ARIPIPRAZOLE
TABLET, ORALLY DISINTEGRATING; ORAL
ABILIFY
>D> OTSUKA 20MG N21729 004 Jun 07, 2006 Apr DISC
>A> @ 20MG N21729 004 Jun 07, 2006 Apr DISC
>D> 30MG N21729 005 Jun 07, 2006 Apr DISC
>A> @ 30MG N21729 005 Jun 07, 2006 Apr DISC
ATROPINE SULFATE; DIPHENOXYLATE HYDROCHLORIDE
TABLET; ORAL
DIPHENOXYLATE HYDROCHLORIDE W/ ATROPINE SULFATE
>D> @ LEINER 0.025MG;2.5MG N85766 001 Apr CAHN
>A> @ PVT FORM 0.025MG;2.5MG N85766 001 Apr CAHN
BENZTHIAZIDE
TABLET; ORAL
BENZTHIAZIDE
>D> @ LEINER 50MG N83206 001 Apr CAHN
>A> @ PVT FORM 50MG N83206 001 Apr CAHN
BUMETANIDE
INJECTABLE; INJECTION
BUMETANIDE
>A> AP BAXTER HLTHCARE 0.25MG/ML N79196 001 Apr 30, 2008 Apr NEWA
BUPIVACAINE HYDROCHLORIDE; EPINEPHRINE
INJECTABLE; INJECTION
BUPIVACAINE HYDROCHLORIDE AND EPINEPHRINE
>D> HOSPIRA 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Apr DISC
>A> @ 0.5%;0.005MG/ML N71169 001 Jun 16, 1988 Apr DISC
>D> + 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Apr DISC
>A> @ 0.75%;0.005MG/ML N71171 001 Jun 16, 1988 Apr DISC
>A> BUPROPION HYDROBROMIDE
>A> TABLET, EXTENDED RELEASE; ORAL
>A> APLENZIN
>A> + BIOVAIL LABS INTL 174MG N22108 001 Apr 23, 2008 Apr NEWA
>A> 348MG N22108 002 Apr 23, 2008 Apr NEWA
>A> 522MG N22108 003 Apr 23, 2008 Apr NEWA
CABERGOLINE
TABLET; ORAL
CABERGOLINE
>A> AB COBALT LABS INC 0.5MG N78035 001 Apr 21, 2008 Apr NEWA
>D> AB PAR PHARM 0.5MG N76310 001 Dec 29, 2005 Apr CRLD
>A> AB + 0.5MG N76310 001 Dec 29, 2005 Apr CRLD
>D> DOSTINEX
>D> AB + PHARMACIA AND 0.5MG N20664 001 Dec 23, 1996 Apr DISC
>A> @ 0.5MG N20664 001 Dec 23, 1996 Apr DISC
CALCIPOTRIENE
SOLUTION; TOPICAL
>A> CALCIPOTRIENE
>A> AT NYCOMED US 0.005% N78305 001 May 06, 2008 Apr NEWA
DOVONEX
>D> + LEO PHARM 0.005% N20611 001 Mar 03, 1997 Apr CFTG
>A> AT + 0.005% N20611 001 Mar 03, 1997 Apr CFTG
CALCIUM ACETATE
TABLET; ORAL
CALCIUM ACETATE
>D> + ROXANE EQ 169MG CALCIUM N77693 001 Jan 30, 2008 Apr DISC
>A> @ EQ 169MG CALCIUM N77693 001 Jan 30, 2008 Apr DISC
CARBOPLATIN
INJECTABLE; IV (INFUSION)
CARBOPLATIN
>A> AP EBEWE PHARMA EQ 50MG/5ML(10MG/ML) N78280 001 May 08, 2008 Apr NEWA
>A> AP EQ 150MG/15ML(10MG/ML) N78280 002 May 08, 2008 Apr NEWA
>A> AP EQ 450MG/45ML(10MG/ML) N78280 003 May 08, 2008 Apr NEWA
CEFIXIME
TABLET; ORAL
SUPRAX
>D> @ LUPIN 400MG N65130 001 Feb 12, 2004 Apr CMFD
>A> + 400MG N65130 001 Feb 12, 2004 Apr CMFD
CHLORPHENIRAMINE MALEATE
TABLET; ORAL
CHLORPHENIRAMINE MALEATE
>D> @ LEINER 4MG N80786 001 Apr CAHN
>A> @ PVT FORM 4MG N80786 001 Apr CAHN
CHLORPROMAZINE HYDROCHLORIDE
TABLET; ORAL
CHLORPROMAZINE HYDROCHLORIDE
>D> @ LEINER 25MG N80340 001 Apr CAHN
>D> @ 50MG N80340 002 Apr CAHN
>D> @ 200MG N80340 003 Apr CAHN
>A> @ PVT FORM 25MG N80340 001 Apr CAHN
>A> @ 50MG N80340 002 Apr CAHN
>A> @ 200MG N80340 003 Apr CAHN
CIPROFLOXACIN
INJECTABLE; INJECTION
CIPROFLOXACIN
>A> AP CLARIS 200MG/20ML (10MG/ML) N78062 001 Apr 29, 2008 Apr NEWA
>A> AP 400MG/40ML (10MG/ML) N78062 002 Apr 29, 2008 Apr NEWA
CIPROFLOXACIN IN DEXTROSE 5% IN PLASTIC CONTAINER
>A> AP HIKMA 200MG/100ML N76757 001 Apr 21, 2008 Apr NEWA
>D> CITRIC ACID; MAGNESIUM OXIDE; SODIUM CARBONATE
>D> SOLUTION; IRRIGATION
>D> UROLOGIC G IN PLASTIC CONTAINER
>D> + HOSPIRA 3.24GM/100ML;380MG/100ML;430MG/ N18904 001 May 27, 1983 Apr DISC
>A> @ 3.24GM/100ML;380MG/100ML;430MG/ N18904 001 May 27, 1983 Apr DISC
CLINDAMYCIN PHOSPHATE
SOLUTION; TOPICAL
CLINDAMYCIN PHOSPHATE
>A> @ BOCA PHARMA EQ 1% BASE N62930 001 Jun 28, 1989 Apr CAHN
>D> @ TEVA EQ 1% BASE N62930 001 Jun 28, 1989 Apr CAHN
COLCHICINE; PROBENECID
TABLET; ORAL
COL-PROBENECID
>D> BP + WATSON LABS 0.5MG;500MG N84279 001 Apr CTEC
>A> BP + 0.5MG;500MG N84279 001 Apr CTEC
PROBENECID AND COLCHICINE
>A> AB CONCORD LABS NJ 0.5MG;500MG N40618 001 May 13, 2008 Apr NEWA
CYCLOBENZAPRINE HYDROCHLORIDE
TABLET; ORAL
CYCLOBENZAPRINE HYDROCHLORIDE
>A> AB RANBAXY 5MG N78722 001 May 12, 2008 Apr NEWA
>A> AB 7.5MG N78722 002 May 12, 2008 Apr NEWA
>A> AB 10MG N78722 003 May 12, 2008 Apr NEWA
>D> WATSON LABS 7.5MG N71611 003 Feb 03, 2006 Apr CTEC
>A> AB 7.5MG N71611 003 Feb 03, 2006 Apr CTEC
DEXAMETHASONE
TABLET; ORAL
DEXAMETHASONE
>D> @ LEINER 0.75MG N83420 001 Apr CAHN
>A> @ PVT FORM 0.75MG N83420 001 Apr CAHN
DIGOXIN
INJECTABLE; INJECTION
>D> DIGOXIN PEDIATRIC
>D> AP HOSPIRA 0.1MG/ML N40092 001 Apr 25, 1996 Apr DISC
>A> @ 0.1MG/ML N40092 001 Apr 25, 1996 Apr DISC
LANOXIN PEDIATRIC
>D> AP + GLAXOSMITHKLINE 0.1MG/ML N09330 004 Apr CTEC
>A> + 0.1MG/ML N09330 004 Apr CTEC
DIPHENHYDRAMINE HYDROCHLORIDE
CAPSULE; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
>D> @ LEINER 25MG N83027 001 Apr CAHN
>D> @ 50MG N83027 002 Apr CAHN
>A> @ PVT FORM 25MG N83027 001 Apr CAHN
>A> @ 50MG N83027 002 Apr CAHN
ELIXIR; ORAL
DIPHENHYDRAMINE HYDROCHLORIDE
>D> @ LEINER 12.5MG/5ML N85287 001 Apr CAHN
>A> @ PVT FORM 12.5MG/5ML N85287 001 Apr CAHN
DIPYRIDAMOLE
TABLET; ORAL
DIPYRIDAMOLE
>A> AB LANNETT 25MG N40898 001 Apr 23, 2008 Apr NEWA
>A> AB 50MG N40898 002 Apr 23, 2008 Apr NEWA
>A> AB 75MG N40898 003 Apr 23, 2008 Apr NEWA
DONEPEZIL HYDROCHLORIDE
TABLET; ORAL
ARICEPT
>D> EISAI MEDCL RES 5MG N20690 002 Nov 25, 1996 Apr CFTG
>A> AB 5MG N20690 002 Nov 25, 1996 Apr CFTG
>D> + 10MG N20690 001 Nov 25, 1996 Apr CFTG
>A> AB + 10MG N20690 001 Nov 25, 1996 Apr CFTG
>A> DONEPEZIL HYDROCHLORIDE
>A> AB TEVA 5MG N77344 001 Apr 28, 2008 Apr NEWA
>A> AB 10MG N77344 002 Apr 28, 2008 Apr NEWA
DOXYCYCLINE
CAPSULE, DELAYED RELEASE; ORAL
ORACEA
>D> + COLLAGENEX 40MG N50805 001 May 26, 2006 Apr CAHN
>A> + GALDERMA LABS LP 40MG N50805 001 May 26, 2006 Apr CAHN
DOXYCYCLINE HYCLATE
CAPSULE; ORAL
DOXYCYCLINE HYCLATE
>D> @ LEINER EQ 100MG BASE N62631 002 Jul 24, 1986 Apr CAHN
>A> @ PVT FORM EQ 100MG BASE N62631 002 Jul 24, 1986 Apr CAHN
TABLET; ORAL
PERIOSTAT
>D> AB + COLLAGENEX EQ 20MG BASE N50783 001 Feb 02, 2001 Apr CAHN
>A> AB + GALDERMA LABS LP EQ 20MG BASE N50783 001 Feb 02, 2001 Apr CAHN
DROSPIRENONE; ETHINYL ESTRADIOL
TABLET; ORAL-28
>A> DROSPIRENONE AND ETHINYL ESTRADIOL
>A> AB BARR 3MG;0.03MG N77527 001 May 09, 2008 Apr NEWA
YASMIN
>D> + BAYER HLTHCARE 3MG;0.03MG N21098 001 May 11, 2001 Apr CFTG
>A> AB + 3MG;0.03MG N21098 001 May 11, 2001 Apr CFTG
EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE
>D> AP HOSPIRA 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Apr DISC
>A> @ 0.005MG/ML;1.5% N89650 001 Jun 21, 1988 Apr DISC
>A> AP 0.01MG/ML;2% N78772 001 May 12, 2008 Apr NEWA
>A> AP 0.02MG/ML;2% N78772 002 May 12, 2008 Apr NEWA
XYLOCAINE W/ EPINEPHRINE
>D> + DENTSPLY PHARM 0.01MG/ML;2% N21381 001 Apr CFTG
>A> AP + 0.01MG/ML;2% N21381 001 Apr CFTG
>D> + 0.02MG/ML;2% N21381 002 Apr CFTG
>A> AP + 0.02MG/ML;2% N21381 002 Apr CFTG
EPOPROSTENOL SODIUM
INJECTABLE; INJECTION
>A> EPOPROSTENOL SODIUM
>A> AP TEVA PARENTERAL EQ 0.5MG BASE/VIAL N78396 001 Apr 23, 2008 Apr NEWA
>A> AP EQ 1.5MG BASE/VIAL N78396 002 Apr 23, 2008 Apr NEWA
FLOLAN
>D> + GLAXOSMITHKLINE EQ 0.5MG BASE/VIAL N20444 001 Sep 20, 1995 Apr CFTG
>A> AP + EQ 0.5MG BASE/VIAL N20444 001 Sep 20, 1995 Apr CFTG
>D> + EQ 1.5MG BASE/VIAL N20444 002 Sep 20, 1995 Apr CFTG
>A> AP + EQ 1.5MG BASE/VIAL N20444 002 Sep 20, 1995 Apr CFTG
ESTROGENS, ESTERIFIED
TABLET; ORAL
ESTERIFIED ESTROGENS
>D> @ LEINER 0.625MG N83414 001 Apr CAHN
>D> @ 1.25MG N83765 001 Apr CAHN
>D> @ 2.5MG N85907 001 Apr CAHN
>A> @ PVT FORM 0.625MG N83414 001 Apr CAHN
>A> @ 1.25MG N83765 001 Apr CAHN
>A> @ 2.5MG N85907 001 Apr CAHN
FEMOGEN
>D> @ LEINER 0.625MG N85076 001 Apr CAHN
>D> @ 1.25MG N85008 001 Apr CAHN
>D> @ 2.5MG N85007 001 Apr CAHN
>A> @ PVT FORM 0.625MG N85076 001 Apr CAHN
>A> @ 1.25MG N85008 001 Apr CAHN
>A> @ 2.5MG N85007 001 Apr CAHN
ETHIONAMIDE
TABLET; ORAL
>A> TRECATOR
>A> + WYETH PHARMS 250MG N13026 002 Apr CTNA
>D> TRECATOR-SC
>D> + WYETH PHARMS 250MG N13026 002 Apr CTNA
FENOFIBRATE
TABLET; ORAL
FENOFIBRATE
>D> LIFECYCLE 40MG N22118 001 Aug 10, 2007 Apr CAHN
>D> + 120MG N22118 002 Aug 10, 2007 Apr CAHN
>A> SCIELE PHARMA 40MG N22118 001 Aug 10, 2007 Apr CAHN
>A> + 120MG N22118 002 Aug 10, 2007 Apr CAHN
FLUMAZENIL
INJECTABLE; INJECTION
>A> AP FLAKORN STRIDES 0.5MG/5ML(0.1MG/ML) N78595 001 May 13, 2008 Apr NEWA
>A> AP 1MG/10ML(0.1MG/ML) N78595 002 May 13, 2008 Apr NEWA
FLUVOXAMINE MALEATE
TABLET; ORAL
LUVOX
>A> AB JAZZ 25MG N21519 001 Dec 20, 2007 Apr CAHN
>A> AB 50MG N21519 002 Dec 20, 2007 Apr CAHN
>A> AB 100MG N21519 003 Dec 20, 2007 Apr CAHN
>D> AB SOLVAY 25MG N21519 001 Dec 20, 2007 Apr CAHN
>D> AB 50MG N21519 002 Dec 20, 2007 Apr CAHN
>D> AB 100MG N21519 003 Dec 20, 2007 Apr CAHN
FUROSEMIDE
INJECTABLE; INJECTION
FUROSEMIDE
>D> AP HOSPIRA 10MG/ML N74337 001 Oct 31, 1994 Apr DISC
>A> @ 10MG/ML N74337 001 Oct 31, 1994 Apr DISC
GRANISETRON HYDROCHLORIDE
INJECTABLE; INJECTION
GRANISETRON HYDROCHLORIDE
>A> AP EBEWE PARENTA EQ 0.1MG BASE/ML (EQ 0.1MG N78808 001 Apr 29, 2008 Apr NEWA
GRISEOFULVIN, MICROCRYSTALLINE
SUSPENSION; ORAL
GRISEOFULVIN
>A> AB PERRIGO CO 125MG/5ML N65200 001 Mar 02, 2005 Apr CAHN
>D> AB STIEFEL 125MG/5ML N65200 001 Mar 02, 2005 Apr CAHN
HYDROCHLOROTHIAZIDE
TABLET; ORAL
HYDROCHLOROTHIAZIDE
>D> @ LEINER 50MG N86597 001 Apr CAHN
>A> @ PVT FORM 50MG N86597 001 Apr CAHN
IBUPROFEN
TABLET; ORAL
IBUPROFEN
>D> AB LEINER 300MG N71266 001 Oct 15, 1986 Apr DISC
>A> @ 300MG N71266 001 Oct 15, 1986 Apr DISC
IRINOTECAN HYDROCHLORIDE
INJECTABLE; INJECTION
IRINOTECAN HYDROCHLORIDE
>A> AP SUN PHARMA 40MG/2ML (20MG/ML) N78805 001 Apr 21, 2008 Apr NEWA
>A> AP 100MG/5ML (20MG/ML) N78805 002 Apr 21, 2008 Apr NEWA
ISOPROTERENOL HYDROCHLORIDE
INJECTABLE; INJECTION
ISOPROTERENOL HYDROCHLORIDE
>D> HOSPIRA 0.02MG/ML N83283 001 Apr DISC
>A> @ 0.02MG/ML N83283 001 Apr DISC
LEUPROLIDE ACETATE
INLUPRON
>A> AP + ABBOTT ENDO 1MG/0.2ML N19010 001 Apr 09, 1985 Apr CAHN
>D> AP + TAP PHARM 1MG/0.2ML N19010 001 Apr 09, 1985 Apr CAHN
LUPRON DEPOT
>A> + ABBOTT ENDO 3.75MG/VIAL N20011 001 Oct 22, 1990 Apr CAHN
>A> + 7.5MG/VIAL N19732 001 Jan 26, 1989 Apr CAHN
>A> + 22.5MG/VIAL N20517 001 Dec 22, 1995 Apr CAHN
>D> + TAP PHARM 3.75MG/VIAL N20011 001 Oct 22, 1990 Apr CAHN
>D> + 7.5MG/VIAL N19732 001 Jan 26, 1989 Apr CAHN
>D> + 22.5MG/VIAL N20517 001 Dec 22, 1995 Apr CAHN
LUPRON DEPOT-3
>A> + ABBOTT ENDO 11.25MG/VIAL N20708 001 Mar 07, 1997 Apr CAHN
>D> + TAP PHARM 11.25MG/VIAL N20708 001 Mar 07, 1997 Apr CAHN
LUPRON DEPOT-4
>A> + ABBOTT ENDO 30MG/VIAL N20517 002 May 30, 1997 Apr CAHN
>D> + TAP PHARM 30MG/VIAL N20517 002 May 30, 1997 Apr CAHN
>A> @ ABBOTT ENDO 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>A> + 7.5MG/VIAL N20263 002 Apr 16, 1993 Apr CAHN
>A> @ 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>A> @ 7.5MG/VIAL,7.5MG/VIAL N20263 004 Apr 16, 1993 Apr CAHN
>A> + 11.25MG/VIAL N20263 005 Jan 21, 1994 Apr CAHN
>A> + 15MG/VIAL N20263 006 Jan 21, 1994 Apr CAHN
>D> @ TAP PHARM 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>D> + 7.5MG/VIAL N20263 002 Apr 16, 1993 Apr CAHN
>D> @ 3.75MG/VIAL,7.5MG/VIAL N20263 003 Apr 16, 1993 Apr CAHN
>D> @ 7.5MG/VIAL,7.5MG/VIAL N20263 004 Apr 16, 1993 Apr CAHN
>D> + 11.25MG/VIAL N20263 005 Jan 21, 1994 Apr CAHN
>D> + 15MG/VIAL N20263 006 Jan 21, 1994 Apr CAHN
LIDOCAINE HYDROCHLORIDE
INJECTABLE; INJECTION
XYLOCAINE PRESERVATIVE FREE
>D> AP ABRAXIS 1% N16801 005 Jan 19, 1988 Apr CAHN
>D> AP + 2% N16801 001 Apr CAHN
>D> AP 4% N16801 002 Apr CAHN
>D> AP + 10% N16801 003 Apr CAHN
>D> AP + 20% N16801 004 Apr CAHN
>A> AP APP PHARMS 1% N16801 005 Jan 19, 1988 Apr CAHN
>A> AP + 2% N16801 001 Apr CAHN
>A> AP 4% N16801 002 Apr CAHN
>A> AP + 10% N16801 003 Apr CAHN
>A> AP + 20% N16801 004 Apr CAHN
LUBIPROSTONE
CAPSULE; ORAL
AMITIZA
>A> SUCAMPO PHARMS 8UGM N21908 002 Apr 29, 2008 Apr NEWA
MEPIVACAINE HYDROCHLORIDE
INJECTABLE; INJECTION
MEPIVACAINE HYDROCHLORIDE
>A> AP HOSPIRA INC 3% N40806 001 Apr 28, 2008 Apr NEWA
MEPROBAMATE
TABLET; ORAL
MEPROBAMATE
>D> @ LEINER 400MG N14601 001 Apr CAHN
>A> @ PVT FORM 400MG N14601 001 Apr CAHN
METHSCOPOLAMINE BROMIDE
TABLET; ORAL
METHSCOPOLAMINE BROMIDE
>D> @ LEINER 2.5MG N80970 001 Apr CAHN
>A> @ PVT FORM 2.5MG N80970 001 Apr CAHN
>A> METHYLNALTREXONE BROMIDE
>A> SOLUTION; SUBCUTANEOUS
>A> RELISTOR
>A> + PROGENICS 12MG/0.6ML (12MG/0.6ML) N21964 001 Apr 24, 2008 Apr NEWA
METHYLPHENIDATE
FILM, EXTENDED RELEASE; TRANSDERMAL
DAYTRANA
>D> + SHIRE 10MG/9HR (1.1MG/HR) N21514 001 Apr 06, 2006 Apr CRLD
>A> 10MG/9HR (1.1MG/HR) N21514 001 Apr 06, 2006 Apr CRLD
>D> + 15MG/9HR (1.6MG/HR) N21514 002 Apr 06, 2006 Apr CRLD
>A> 15MG/9HR (1.6MG/HR) N21514 002 Apr 06, 2006 Apr CRLD
>D> + 20MG/9HR (2.2MG/HR) N21514 003 Apr 06, 2006 Apr CRLD
>A> 20MG/9HR (2.2MG/HR) N21514 003 Apr 06, 2006 Apr CRLD
METHYLTESTOSTERONE
TABLET; BUCCAL/SUBLINGUAL
METHYLTESTOSTERONE
>D> @ LEINER 5MG N83836 001 Apr CAHN
>A> @ PVT FORM 5MG N83836 001 Apr CAHN
TABLET; ORAL
METHYLTESTOSTERONE
>D> @ LEINER 5MG N80214 001 Apr CAHN
>D> @ 10MG N80214 002 Apr CAHN
>D> @ 25MG N80214 003 Apr CAHN
>A> @ PVT FORM 5MG N80214 001 Apr CAHN
>A> @ 10MG N80214 002 Apr CAHN
>A> @ 25MG N80214 003 Apr CAHN
METOPROLOL TARTRATE
INJECTABLE; INJECTION
METOPROLOL TARTRATE
>A> AP HOSPIRA 1MG/ML N78085 001 Apr 29, 2008 Apr NEWA
MINOCYCLINE HYDROCHLORIDE
CAPSULE; ORAL
MINOCYCLINE HYDROCHLORIDE
>D> AB TEVA EQ 100MG BASE N63009 001 Mar 02, 1992 Apr CRLD
>A> AB + EQ 100MG BASE N63009 001 Mar 02, 1992 Apr CRLD
MITOXANTRONE HYDROCHLORIDE
INJECTABLE; INJECTION
MITOXANTRONE HYDROCHLORIDE
>A> AP DABUR ONCOLOGY EQ 20MG BASE/10ML(2MG/ML) N78606 001 May 14, 2008 Apr NEWA
>A> AP EQ 25MG BASE/12.5ML(2MG/ML) N78606 002 May 14, 2008 Apr NEWA
>A> AP EQ 30MG BASE/15ML (2MG/ML) N78606 003 May 14, 2008 Apr NEWA
>A> NAPROXEN SODIUM; SUMATRIPTAN SUCCINATE
>A> TABLET; ORAL
>A> TREXIMET
>A> + POZEN 500MG;EQ 85MG BASE N21926 001 Apr 15, 2008 Apr NEWA
NICARDIPINE HYDROCHLORIDE
CAPSULE, EXTENDED RELEASE; ORAL
CARDENE SR
>A> + EKR THERAP 30MG N20005 001 Feb 21, 1992 Apr CAHN
>A> + 45MG N20005 002 Feb 21, 1992 Apr CAHN
>A> + 60MG N20005 003 Feb 21, 1992 Apr CAHN
>D> + PDL BIOPHARMA 30MG N20005 001 Feb 21, 1992 Apr CAHN
>D> + 45MG N20005 002 Feb 21, 1992 Apr CAHN
>D> + 60MG N20005 003 Feb 21, 1992 Apr CAHN
CAPSULE; ORAL
CARDENE
>A> AB EKR THERAP 20MG N19488 001 Dec 21, 1988 Apr CAHN
>A> AB + 30MG N19488 002 Dec 21, 1988 Apr CAHN
>D> AB PDL BIOPHARMA 20MG N19488 001 Dec 21, 1988 Apr CAHN
>D> AB + 30MG N19488 002 Dec 21, 1988 Apr CAHN
INJECTABLE; INJECTION
CARDENE
>A> + EKR THERAP 2.5MG/ML N19734 001 Jan 30, 1992 Apr CAHN
>D> + PDL BIOPHARMA 2.5MG/ML N19734 001 Jan 30, 1992 Apr CAHN
NYSTATIN
SUSPENSION; ORAL
NILSTAT
>A> AA + GLENMARK 100,000 UNITS/ML N50299 001 Apr CAHN
>D> AA + GLENMARK 100,000 UNITS/ML N50299 001 Apr CAHN
OFLOXACIN
>D> INJECTABLE; INJECTION
>D> OFLOXACIN
>D> + BEDFORD 40MG/ML N75762 001 Jan 16, 2002 Apr DISC
>A> @ 40MG/ML N75762 001 Jan 16, 2002 Apr DISC
OLOPATADINE HYDROCHLORIDE
SOLUTION/DROPS; OPHTHALMIC
PATADAY
>D> + ALCON 0.2% N21545 001 Dec 22, 2004 Apr CPOT
>A> + EQ 0.2% BASE N21545 001 Dec 22, 2004 Apr CPOT
>A> SPRAY, METERED; NASAL
>A> + PAALCON 0.665MG/SPRAY N21861 001 Apr 15, 2008 Apr NEWA
ONDANSETRON HYDROCHLORIDE
INJECTABLE; INJECTION
ONDANSETRON HYDROCHLORIDE
>A> AP AKORN STRIDES EQ 2MG BASE/ML N78257 001 Apr 23, 2008 Apr NEWA
ONDANSETRON HYDROCHLORIDE PRESERVATIVE FREE
>A> AP AKORN STRIDES EQ 2MG BASE/ML N78244 001 Apr 23, 2008 Apr NEWA
PENICILLIN V POTASSIUM
TABLET; ORAL
PENICILLIN V POTASSIUM
>A> AB AUROBINDO EQ 250MG BASE N65435 001 Apr 29, 2008 Apr NEWA
>A> AB EQ 500MG BASE N65435 002 Apr 29, 2008 Apr NEWA
PHENDIMETRAZINE TARTRATE
TABLET; ORAL
DI-METREX
>D> @ LEINER 35MG N85698 001 Apr CAHN
>A> @ PVT FORM 35MG N85698 001 Apr CAHN
PHENDIMETRAZINE TARTRATE
>D> @ LEINER 35MG N85697 001 Apr CAHN
>D> @ 35MG N85199 001 Apr CAHN
>A> @ PVT FORM 35MG N85697 001 Apr CAHN
>A> @ 35MG N85199 001 Apr CAHN
PHENTERMINE HYDROCHLORIDE
CAPSULE; ORAL
PHENTERMINE HYDROCHLORIDE
>A> AA KVK TECH 37.5MG N40887 001 Apr 24, 2008 Apr NEWA
PRAVASTATIN SODIUM
TABLET; ORAL
PRAVASTATIN SODIUM
>A> AB ZYDUS PHARMS USA 10MG N77751 001 Apr 30, 2008 Apr NEWA
>A> AB 20MG N77751 002 Apr 30, 2008 Apr NEWA
>A> AB 40MG N77751 003 Apr 30, 2008 Apr NEWA
>A> AB 80MG N77751 004 Apr 30, 2008 Apr NEWA
PREDNISOLONE
TABLET; ORAL
PREDNISOLONE
>D> @ LEINER 5MG N80211 001 Apr CAHN
>A> @ PVT FORM 5MG N80211 001 Apr CAHN
PREDNISOLONE SODIUM PHOSPHATE
SOLUTION; ORAL
PREDNISOLONE SODIUM PHOSPHATE
>D> AA PHARM ASSOC EQ 10MG BASE/5ML N78465 001 Mar 07, 2008 Apr CRLD
>A> + EQ 10MG BASE/5ML N78465 001 Mar 07, 2008 Apr CRLD
PREDNISONE
TABLET; ORAL
PREDNISONE
>D> @ LEINER 20MG N85151 001 Apr CAHN
>A> @ PVT FORM 20MG N85151 001 Apr CAHN
PRIMIDONE
TABLET; ORAL
PRIMIDONE
>A> AB AMNEAL PHARM 50MG N40866 001 Apr 23, 2008 Apr NEWA
>A> AB 250MG N40866 002 Apr 23, 2008 Apr NEWA
PROCAINAMIDE HYDROCHLORIDE
INJECTABLE; INJECTION
>D> PRONESTYL
>D> AP + APOTHECON 100MG/ML N07335 002 Apr DISC
>A> @ 100MG/ML N07335 002 Apr DISC
>D> AP + 500MG/ML N07335 005 Apr DISC
>A> @ 500MG/ML N07335 005 Apr DISC
>D> TABLET; ORAL
>D> PRONESTYL
>D> APOTHECON 250MG N17371 001 Apr DISC
>A> @ 250MG N17371 001 Apr DISC
>D> 375MG N17371 002 Apr DISC
>A> @ 375MG N17371 002 Apr DISC
>D> + 500MG N17371 003 Apr DISC
>A> @ 500MG N17371 003 Apr DISC
PROMETHAZINE HYDROCHLORIDE
INJECTABLE; INJECTION
PROMETHAZINE HYDROCHLORIDE
>A> AP HIKMA 25MG/ML N40737 001 Apr 24, 2008 Apr NEWA
>A> AP 50MG/ML N40737 002 Apr 24, 2008 Apr NEWA
>D> AP HOSPIRA 50MG/ML N83838 002 Apr DISC
>A> @ 50MG/ML N83838 002 Apr DISC
TABLET; ORAL
PROMETHAZINE HYDROCHLORIDE
>D> @ LEINER 12.5MG N83214 001 Apr CAHN
>D> @ 25MG N83658 001 Apr CAHN
>A> @ PVT FORM 12.5MG N83214 001 Apr CAHN
>A> @ 25MG N83658 001 Apr CAHN
>D> BP WATSON LABS 25MG N83426 001 Apr CTEC
>A> AB 25MG N83426 001 Apr CTEC
>D> BP 50MG N83711 001 Apr CTEC
>A> AB 50MG N83711 001 Apr CTEC
PROPANTHELINE BROMIDE
TABLET; ORAL
PROPANTHELINE BROMIDE
>D> @ LEINER 15MG N80977 001 Apr CAHN
>A> @ PVT FORM 15MG N80977 001 Apr CAHN
PROPOXYPHENE HYDROCHLORIDE
CAPSULE; ORAL
PROPOXYPHENE HYDROCHLORIDE
>D> @ LEINER 32MG N83464 001 Apr CAHN
>D> @ 65MG N83113 001 Apr CAHN
>A> @ PVT FORM 32MG N83464 001 Apr CAHN
>A> @ 65MG N83113 001 Apr CAHN
PSEUDOEPHEDRINE HYDROCHLORIDE; TRIPROLIDINE HYDROCHLORIDE
TABLET; ORAL
ALLERFED
>D> @ LEINER 60MG;2.5MG N88860 001 Jan 31, 1985 Apr CAHN
>A> @ PVT FORM 60MG;2.5MG N88860 001 Jan 31, 1985 Apr CAHN
QUETIAPINE FUMARATE
TABLET, EXTENDED RELEASE; ORAL
SEROQUEL XR
>D> ASTRAZENECA EQ 50MG BASE N22047 001 May 17, 2007 Apr DISC
>A> @ EQ 50MG BASE N22047 001 May 17, 2007 Apr DISC
RAMIPRIL
CAPSULE; ORAL
RAMIPRIL
>D> AB COBALT 1.25MG N76549 001 Oct 24, 2005 Apr CAHN
>D> AB 2.5MG N76549 002 Oct 24, 2005 Apr CAHN
>D> AB 5MG N76549 003 Oct 24, 2005 Apr CAHN
>D> AB 10MG N76549 004 Oct 24, 2005 Apr CAHN
>A> AB COBALT LABS INC 1.25MG N76549 001 Oct 24, 2005 Apr CAHN
>A> AB 2.5MG N76549 002 Oct 24, 2005 Apr CAHN
>A> AB 5MG N76549 003 Oct 24, 2005 Apr CAHN
>A> AB 10MG N76549 004 Oct 24, 2005 Apr CAHN
RAUWOLFIA SERPENTINA
TABLET; ORAL
RAUWOLFIA SERPENTINA
>D> @ LEINER 50MG N80583 001 Apr CAHN
>D> @ 100MG N80583 002 Apr CAHN
>A> @ PVT FORM 50MG N80583 001 Apr CAHN
>A> @ 100MG N80583 002 Apr CAHN
>A> REGADENOSON
>A> INJECTABLE; INJECTION
>A> LEXISCAN
>A> + CV THERAP 0.4MG/5ML (0.08MG/ML) N22161 001 Apr 10, 2008 Apr NEWA
RESERPINE
TABLET; ORAL
RESERPINE
>D> @ LEINER 0.1MG N86117 001 Apr CAHN
>D> @ 0.25MG N85775 001 Apr CAHN
>D> @ 0.25MG N80582 001 Apr CAHN
>D> @ 1MG N80582 002 Apr CAHN
>A> @ PVT FORM 0.1MG N86117 001 Apr CAHN
>A> @ 0.25MG N85775 001 Apr CAHN
>A> @ 0.25MG N80582 001 Apr CAHN
>A> @ 1MG N80582 002 Apr CAHN
RIBAVIRIN
TABLET; ORAL
RIBAVIRIN
>A> ZYDUS PHARMS USA 500MG N77094 004 Apr 18, 2008 Apr NEWA
RISEDRONATE SODIUM
TABLET; ORAL
ACTONEL
>A> PROCTER AND 150MG N20835 005 Apr 22, 2008 Apr NEWA
ROPINIROLE HYDROCHLORIDE
TABLET; ORAL
REQUIP
>D> + GLAXOSMITHKLINE EQ 0.25MG BASE N20658 001 Sep 19, 1997 Apr CFTG
>A> AB + EQ 0.25MG BASE N20658 001 Sep 19, 1997 Apr CFTG
>D> EQ 0.5MG BASE N20658 002 Sep 19, 1997 Apr CFTG
>A> AB EQ 0.5MG BASE N20658 002 Sep 19, 1997 Apr CFTG
>D> EQ 1MG BASE N20658 003 Sep 19, 1997 Apr CFTG
>A> AB EQ 1MG BASE N20658 003 Sep 19, 1997 Apr CFTG
>D> EQ 2MG BASE N20658 004 Sep 19, 1997 Apr CFTG
>A> AB EQ 2MG BASE N20658 004 Sep 19, 1997 Apr CFTG
>D> EQ 3MG BASE N20658 006 Jan 27, 1999 Apr CFTG
>A> AB EQ 3MG BASE N20658 006 Jan 27, 1999 Apr CFTG
>D> EQ 4MG BASE N20658 007 Jan 27, 1999 Apr CFTG
>A> AB EQ 4MG BASE N20658 007 Jan 27, 1999 Apr CFTG
>A> ROPINIROLE HYDROCHLORIDE
>A> AB MYLAN EQ 0.25MG BASE N78881 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N78881 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N78881 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N78881 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N78881 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N78881 006 May 05, 2008 Apr NEWA
>A> AB PAR PHARM EQ 0.25MG BASE N78110 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N78110 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N78110 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N78110 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N78110 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N78110 006 May 05, 2008 Apr NEWA
>A> AB ROXANE EQ 0.25MG BASE N77852 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N77852 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N77852 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N77852 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N77852 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N77852 006 May 05, 2008 Apr NEWA
>A> AB TEVA EQ 0.25MG BASE N77460 001 May 05, 2008 Apr NEWA
>A> AB EQ 0.5MG BASE N77460 002 May 05, 2008 Apr NEWA
>A> AB EQ 1MG BASE N77460 003 May 05, 2008 Apr NEWA
>A> AB EQ 2MG BASE N77460 004 May 05, 2008 Apr NEWA
>A> AB EQ 3MG BASE N77460 005 May 05, 2008 Apr NEWA
>A> AB EQ 4MG BASE N77460 006 May 05, 2008 Apr NEWA
>D> ROTIGOTINE
>D> FILM, EXTENDED RELEASE; TRANSDERMAL
>D> NEUPRO
>D> SCHWARZ 2MG/24HR N21829 001 May 09, 2007 Apr DISC
>A> @ 2MG/24HR N21829 001 May 09, 2007 Apr DISC
>D> 4MG/24HR N21829 002 May 09, 2007 Apr DISC
>A> @ 4MG/24HR N21829 002 May 09, 2007 Apr DISC
>D> + 6MG/24HR N21829 003 May 09, 2007 Apr DISC
>A> @ 6MG/24HR N21829 003 May 09, 2007 Apr DISC
SODIUM LACTATE
INJECTABLE; INJECTION
SODIUM LACTATE 0.167 MOLAR IN PLASTIC CONTAINER
>D> AP HOSPIRA 1.87GM/100ML N18249 001 Apr DISC
>A> @ 1.87GM/100ML N18249 001 Apr DISC
TETRACYCLINE HYDROCHLORIDE
CAPSULE; ORAL
TETRACYCLINE HYDROCHLORIDE
>D> @ LEINER 250MG N62686 001 Jul 24, 1986 Apr CAHN
>D> @ 500MG N62686 002 Jul 24, 1986 Apr CAHN
>A> @ PVT FORM 250MG N62686 001 Jul 24, 1986 Apr CAHN
>A> @ 500MG N62686 002 Jul 24, 1986 Apr CAHN
THALLOUS CHLORIDE, TL-201
INJECTABLE; INTRAVENOUS
THALLOUS CHLORIDE TL 201
>A> AP MALLINCKRODT 2mCi/ML N77698 001 Nov 09, 2006 Apr CAHN
>D> AP TCI MEDCL 2mCi/ML N77698 001 Nov 09, 2006 Apr CAHN
TIMOLOL MALEATE
SOLUTION/DROPS; OPHTHALMIC
TIMOLOL MALEATE
>A> AT FDC LTD EQ 0.25% BASE N77259 001 Apr 30, 2008 Apr NEWA
>A> AT EQ 0.5% BASE N77259 002 Apr 30, 2008 Apr NEWA
TRANDOLAPRIL
TABLET; ORAL
TRANDOLAPRIL
>A> AB MYLAN 1MG N78346 001 Apr 28, 2008 Apr NEWA
>A> AB 2MG N78346 002 Apr 28, 2008 Apr NEWA
>A> AB 4MG N78346 003 Apr 28, 2008 Apr NEWA
VECURONIUM BROMIDE
INJECTABLE; INJECTION
VECURONIUM BROMIDE
>D> + HOSPIRA 4MG/VIAL N75558 001 Sep 11, 2001 Apr DISC
>A> @ 4MG/VIAL N75558 001 Sep 11, 2001 Apr DISC
ZIDOVUDINE
TABLET; ORAL
ZIDOVUDINE
>A> AB HETERO DRUGS LTD 300MG N90092 001 Apr 25, 2008 Apr NEWA
ZOLPIDEM TARTRATE
TABLET; ORAL
ZOLPIDEM TARTRATE
>A> AB HIKMA 5MG N78129 001 Apr 30, 2008 Apr NEWA
>A> AB 10MG N78129 002 Apr 30, 2008 Apr NEWA
ADDITIONS/DELETIONS FOR OTC DRUG PRODUCT LIST
CETIRIZINE HYDROCHLORIDE
SYRUP; ORAL
CHILDREN'S CETIRIZINE HYDROCHLORIDE ALLERGY
>A> ACTAVIS MID 5MG/5ML N90378 002 May 09, 2008 Apr NEWA
>A> APOTEX 5MG/5ML N90188 002 Apr 22, 2008 Apr NEWA
>A> RANBAXY 5MG/5ML N90183 002 Apr 24, 2008 Apr NEWA
>A> TARO 5MG/5ML N90182 002 Apr 22, 2008 Apr NEWA
CHILDREN'S CETIRIZINE HYDROCHLORIDE HIVES RELIEF
>A> ACTAVIS MID 5MG/5ML N90378 001 May 09, 2008 Apr NEWA
>A> APOTEX 5MG/5ML N90188 001 Apr 22, 2008 Apr NEWA
>A> RANBAXY 5MG/5ML N90183 001 Apr 24, 2008 Apr NEWA
>A> TARO 5MG/5ML N90182 001 Apr 22, 2008 Apr NEWA
TABLET; ORAL
CETIRIZINE HYDROCHLORIDE ALLERGY
>A> CONTRACT 5MG N76047 001 Dec 27, 2007 Apr CAHN
>A> 10MG N76047 002 Dec 27, 2007 Apr CAHN
>D> PAR PHARM 5MG N76047 001 Dec 27, 2007 Apr CAHN
>D> 10MG N76047 002 Dec 27, 2007 Apr CAHN
CETIRIZINE HYDROCHLORIDE HIVES
>A> CONTRACT 5MG N76047 003 Dec 27, 2007 Apr CAHN
>A> 10MG N76047 004 Dec 27, 2007 Apr CAHN
>D> PAR PHARM 5MG N76047 003 Dec 27, 2007 Apr CAHN
>D> 10MG N76047 004 Dec 27, 2007 Apr CAHN
LOPERAMIDE HYDROCHLORIDE; SIMETHICONE
TABLET, CHEWABLE; ORAL
>D> IMODIUM ADVANCED
>D> + MCNEIL 2MG;125MG N20606 001 Jun 26, 1996 Apr CTNA
>A> IMODIUM MULTI-SYMPTOM RELIEF
>A> + MCNEIL 2MG;125MG N20606 001 Jun 26, 1996 Apr CTNA
TABLET; ORAL
>D> IMODIUM ADVANCED
>D> + MCNEIL CONS 2MG;125MG N21140 001 Nov 30, 2000 Apr CTNA
>A> IMODIUM MULTI-SYMPTOM RELIEF
>A> + MCNEIL CONS 2MG;125MG N21140 001 Nov 30, 2000 Apr CTNA
NICOTINE POLACRILEX
GUM, CHEWING; BUCCAL
NICOTINE POLACRILEX
>A> PERRIGO R AND D EQ 2MG BASE N78967 001 Apr 23, 2008 Apr NEWA
>A> EQ 4MG BASE N78968 001 Apr 23, 2008 Apr NEWA
